Reuters logo
BRIEF-Bionor Pharma Q3 operating loss widens to NOK 24.2 million
November 3, 2015 / 7:21 AM / 2 years ago

BRIEF-Bionor Pharma Q3 operating loss widens to NOK 24.2 million

Nov 3 (Reuters) - Bionor Pharma ASA :

* Q3 revenue 55,000 Norwegian crowns ($6,500) versus 0.0 crowns year ago

* Q3 operating loss 24.2 million crowns versus loss 15.2 million crowns year ago

* Maintains its financial guidance for 2015

* For full year 2015 expects core cost base to be in range of 55 million-63 million crowns

Source text for Eikon:

Further company coverage: ($1 = 8.4744 Norwegian crowns)

Gdynia Newsroom

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below